Does intestinal methane production slow transit and contribute to constipation?

Intestinal methanogenesis is a key metabolic process directly linked to altered gut motility and clinical constipation.

Clinical evidence of delayed transit

• Impact on transit time: Experimental models demonstrate that intraluminal methane exposure slows small intestinal transit by 50% to 60%, leading to increased water absorption and stool desiccation.
• Association with constipation: Breath methane production is highly correlated with constipation and constipation-predominant irritable bowel syndrome (IBS-C). Methane-positive individuals exhibit an approximately 3.5-fold increased risk (odds ratio of ~3.5) of constipation-associated disorders, with breath methane levels correlating directly with transit delay severity.

Mechanistic pathways of methanogenesis

• Dominance of M. smithii: Methanobrevibacter smithii is the dominant human gut methanogen, comprising 80% to 90% of the intestinal archaeal population and colonizing up to 97.5% of individuals.
• Hydrogenotrophic metabolism: M. smithii utilizes specialized [NiFe] hydrogenases to scavenge bacterial-derived hydrogen, reducing carbon dioxide to produce methane according to the stoichiometry: $4\text{H}_2 + \text{CO}_2 \rightarrow \text{CH}_4 + 2\text{H}_2\text{O}$.
• Neuromuscular disruption: Rather than acting as an inert gas, methane functions as an active neuromuscular modulator. It reduces postprandial serotonin signaling from enterochromaffin cells and alters motility by strengthening non-propulsive, segmental contractions while diminishing coordinated peristaltic waves.

Bottom line

• Methanobrevibacter smithii is the dominant gut methanogen that actively consumes hydrogen and carbon dioxide to produce methane. This gas acts directly on the gut to impair peristalsis and modulate serotonin signaling, serving as a primary physiological driver of slowed transit and clinical constipation.